UK Prime Minister Boris Johnson visited Wockhardt's facility to understand the manufacturing status of the Oxford AstraZeneca COVID-19 vaccine for the UK market.
Habil Khorakiwala, Founder Chairman & Group CEO of Wockhardt spoke to CNBC-TV18 about Johnson's visit to the Wrexham plant which lasted 3 hours, and the current status of the COVID-19 vaccine.
On manufacturing, Khorakiwala said, “The arrangement is that we have kept the manufacturing line completely at disposal of the UK government. The Oxford vaccine production should be starting in few weeks. They initially want about 100 million doses of vaccine by early next year which we will make available.”
On current capacity to manufacture the vaccine he said, “Our capacity in UK which we earmarked for the government is 350 million doses of vaccine. In addition we have a significant capacity available in India."
He also said, “We will be prioritising vaccine manufacturing over our other products. We believe as an organisation it is our social responsibility to help manufacture vaccine as fast as possible.”To know more, watch this more.